🇺🇸 FDA
Patent

US 10519188

Cyclic di-nucleotide compounds and methods of use

granted A61KA61K31/7084A61K45/06

Quick answer

US patent 10519188 (Cyclic di-nucleotide compounds and methods of use) held by The Board of Regents of the University of Texas System expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/7084, A61K45/06, A61P, A61P31/00